SPRY ARS Pharmaceuticals, Inc.
4.360USD+1.51%Mkt Cap: 433.59M $P/E: —1d ago
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, …
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.27BUSDP/E 30.7
$22.99BUSDP/E 14.5
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap433.59M USD
Enterprise Value454.88M USD
Revenue (TTM)116.93M USD
Gross Profit63.85M USD
Net Income (TTM)-171.30M USD
Revenue/Share1.18 USD
Last Price4.360 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees195
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.79
PEG—
EV/EBITDA-2.12
EV/Revenue3.89
P/S3.65
P/B34.09
EPS (TTM)-2.18
EPS (Forward)-0.90
52W Range
3.9904% of range13.15
52W High13.15 USD
52W Low3.990 USD
Profitability
Gross Margin75.77%
Oper. Margin-182.62%
EBITDA Margin-183.57%
Profit Margin-203.25%
ROE-149.92%
ROA-52.28%
Growth
Revenue Growth114.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-170.87M USD
CapEx (TTM)339.00K USD
FCF Margin-100.66%
FCF Yield-27.15%
Net Debt27.76M USD
Net Debt/EBITDA-0.13
Balance Sheet
Debt/Equity0.84
Current Ratio3.48
Quick Ratio3.15
Book Value/Sh0.13 USD
Cash/Share1.45 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)22.50 USD
Upside (mean)+416.1%
Target Range15.00 USD – 30.00 USD
15.00+416.1% to mean30.00
# Analysts4
Ownership
Shares Out.99.45M
Float48.03M
Insiders16.18%
Institutions92.08%
Short Interest
Short Ratio14.6d
Short % Float33.45%
Short % Out.23.20%
Shares Short23.07M
Short (prev mo.)22.95M
Technical
SMA 505.231 (-16.6%)
SMA 2008.076 (-46.0%)
Beta1.08
S&P 52W Chg16.45%
Avg Vol (30d)1.54M
Avg Vol (10d)1.37M
Technical Indicators
RSI (14)41.0
MACD-0.3860
MACD Signal-0.4509
MACD Hist.+0.0649
BB Upper5.429 USD
BB Middle4.489 USD
BB Lower3.550 USD
BB Width41.86%
ATR (14)0.3163 USD
Vol Ratio (20d)0.93x